Cure My Disease

Don't miss your cure!

 Log in / Sign up

Does a camera lens offer a path to calmer minds?

NCT ID NCT07803367

Symptom relief Sponsor: Beijing Normal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 09, 2026 · Updated 2 times

Summary

Researchers at Beijing Normal University are testing whether a guided nature photography program can ease mild depression and anxiety in young adults. Around 300 participants with mild emotional distress will be randomly assigned to take nature photos, take photos of human-made objects, or follow a stress management handbook. The photography tasks are delivered through a mobile app over 16 days. The study measures changes in mood, connection to nature, and self-compassion at several points during and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nature-based mindful photography delivered through a mobile app
What this could lead to
If it works, this could offer a simple, low-cost way to ease mild depression and anxiety in young adults and strengthen their connection to nature.
What could go wrong
This is an early-stage trial, and the benefit may be modest or no better than other activities. The intervention relies on participants staying engaged over 16 days, and results may not apply to people with more severe symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * PHQ-9 score ≥ 5 or GAD-7 score ≥ 5 (presence of mild or greater emotional distress). Exclusion Criteria: * PHQ-9 score ≥20 or GAD-7 score ≥15 (severe depressive or anxiety symptoms). * Currently receiving psychological counseling or psychiatric treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety symptoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety symptoms Depressive symptoms Psychological distress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.